22.418 articles found

Sort:

Source record

1-N-Substituted thiocarbamoyl-3-phenyl-5-thienyl-2-pyrazolines: a novel cholinesterase and selective monoamine oxidase B inhibitors for the treatment of Parkinson's and Alzheimer's diseases.

Ucar G, Gokhan N, Yesilada A, Bilgin AA.

Neurosci Lett · 2005-04-12

DOI: 10.1016/j.neulet.2005.03.028PMID: 15925113

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

ALPHA 2B OR 2B/2C ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATION

WHEELER LARRY A, GIL DANIEL W, DONELLO JOHN E.

· 2005-04-08

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

METHOD OF USING (2-IMIDAZOLIN-2-YLAMINO)QUINOXALINES IN THE TREATMENT OF DEMENTIA AND PARKINSONS

TATTON WILLIAM G, WHEELER LARRY A, GIL DANIEL W, DONELLO JOHN E.

· 2005-04-08

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

DUAL BINDING SITE ACETYLCHOLINESTERASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE.

MIGUEL MEDINA PADILLA.

· 2005-04-07

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

ALPHA 2B 0R 2B/2C ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATION.

JOHN E DONELLO.

· 2005-04-06

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

METHOD OF USING (2-IMIDAZOLIN-2-YLAMINO) QINOXALINES IN THE TREATMENT OF DEMENTIA AND PARKINSONS.

JOHN E DONELLO.

· 2005-04-06

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Method of using (2-imidazolin-2-ylamino) qinoxalines in the treatment of Dementia and Parkinsons

TATTON WILLIAM G, WHEELER LARRY A, GIL DANIEL W, DONELLO JOHN E.

· 2005-04-05

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF

JANOSKY Christine Loh, LAI Yvonne Yee-Wen, HAYFLICK Joel S..

· 2005-04-04

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia with non-imidazole alkylamines histamine H3- receptor ligands

SCHWARTZ JEAN-CHARLES, LECOMTE JEANNE-MARIE.

· 2005-04-01

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF PARKINSON'S DISEASE.

HALDSTEAD GORDON W.

· 2005-04-01

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Therapeutic potential of transdifferentiated cells.

Burke ZD, Tosh D.

Clin Sci (Lond) · 2005-04-01

DOI: 10.1042/cs20040335PMID: 15766332

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Source record

Cognitive behavioural therapy (CBT) for carers of patients with Parkinson's disease: a preliminary randomised controlled trial.

Secker DL, Brown RG.

J Neurol Neurosurg Psychiatry · 2005-04-01

DOI: 10.1136/jnnp.2004.042291PMID: 15774433

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Article details View source ↗

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.